Bacterial amidohydrolases and modified 5-fluorocytidine compounds: Novel enzyme-prodrug pairs
Viktorija Preitakaitė, Povilas Barasa, Agota Aučynaitė, Gediminas Plakys, Martyna Koplūnaitė, Simona Zubavičiūtė, Rolandas Meškys · 2023
Read Bacterial amidohydrolases and modified 5-fluorocytidine compounds: Novel enzyme-prodrug pairs by Viktorija Preitakaitė, Povilas Barasa, Agota Aučynaitė, Gediminas Plakys, Martyna Koplūnaitė, Simona Zubavičiūtė, Rolandas Meškys (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10688628.txt.
Description
Viktorija Preitakaitė and colleagues pair bacterial enzymes with new prodrugs for cancer care, in work from 2023. Gene directed therapy sends an enzyme gene into cancer cells to arm a harmless prodrug there. Few enzyme and bond pairs suit that trick, which limits how wide the method can spread.
Two bacterial enzymes were placed in human colon cancer cells grown in the lab. New acyl coated cytidine forms served as prodrugs for the paired enzymes. Cancer cells with either enzyme lost viability sharply after prodrug exposure in tests. Cells without the gene lacked that sharp drop, which shows targeted action. The pairs may widen gene directed therapy for future tumour work.
Catalog record
| CREATOR | Viktorija Preitakaitė, Povilas Barasa, Agota Aučynaitė, Gediminas Plakys, Martyna Koplūnaitė, Simona Zubavičiūtė, Rolandas Meškys |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |